Related Experiment Video
Updated: Jul 22, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
[Possible treatment options for Parkinson's disease]
Nederlands Tijdschrift Voor Tandheelkunde
|March 7, 2019
Summary
Parkinson's disease treatments include medications, physical activity, and therapies for motor and non-motor symptoms. Future research explores surgical options like gene and cell therapy for better disease control.
Area of Science:
- Neurology
- Movement Disorders
- Experimental Therapeutics
Background:
- Parkinson's disease presents with motor and non-motor symptoms, impacting quality of life.
- Current management strategies offer symptomatic relief but not a cure.
Purpose of the Study:
- To provide a comprehensive overview of current and potential future treatments for Parkinson's disease.
- To highlight the role of multidisciplinary approaches in managing Parkinson's disease symptoms.
Main Methods:
- Review of existing literature on Parkinson's disease therapies.
- Analysis of current pharmacological, therapeutic, and surgical interventions.
- Exploration of emerging research in gene therapy, cell therapy, and growth factors.
Main Results:
- Medications address motor and non-motor symptoms, with some experimental options available.
- Physical activity, speech, dysphagia, and cognitive behavioral therapies offer significant benefits.
- Deep brain stimulation is the sole current surgical option, with gene and cell therapies as future possibilities.
Conclusions:
- A combination of pharmacological, therapeutic, and lifestyle interventions is crucial for managing Parkinson's disease.
- Ongoing global research aims to discover novel treatments for better disease control and potential cures.
- While a cure remains uncertain, advancements offer hope for improved patient outcomes.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...